The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Quest Diagnostics Inc

NYSE: DGX
Last

(U.S.) $92.96

Today's change+0.70 +0.76%
Updated January 18 4:02 PM EST. Delayed by at least 15 minutes.
 

Quest Diagnostics Inc

NYSE: DGX
Last

(U.S.) $92.96

Today's change+0.70 +0.76%
Updated January 18 4:02 PM EST. Delayed by at least 15 minutes.

Quest Diagnostics Inc crosses above 20-day moving average

Quest Diagnostics Inc closed up Wednesday by (U.S.)$0.70 or 0.76% to (U.S.)$92.96 and crossing above its 20-day moving average. Shares have lost 0.33% for the last five days, but have gained 41.34% over the last 52 weeks. This security has outperformed the S&P 500 by 20.52% during the last year.

Key company metrics

  • Open(U.S.) $92.71
  • Previous close(U.S.) $92.26
  • High(U.S.) $93.37
  • Low(U.S.) $92.15
  • Bid / Ask(U.S.) $86.31 / (U.S.) $0.00
  • YTD % change+1.15%
  • Volume803,495
  • Average volume (10-day)863,814
  • Average volume (1-month)867,094
  • Average volume (3-month)1,072,032
  • 52-week range(U.S.) $59.66 to (U.S.) $93.84
  • Beta0.67
  • Trailing P/E19.68×
  • P/E 1 year forward18.09×
  • Forward PEG2.24×
  • Indicated annual dividend(U.S.) $1.80
  • Dividend yield1.94%
  • Trailing EPS(U.S.) $4.72
Updated January 18 4:02 PM EST. Delayed by at least 15 minutes.
S&P TSX0.28%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue1,8851,9061,8631,849
Total other revenue--------
Total revenue1,8851,9061,8631,849
Gross profit729753720702
Total cost of revenue1,1561,1531,1431,147
Total operating expense1,5631,4841,6061,610
Selling / general / administrative407429440429
Research & development--------
Depreciation / amortization18171920
Interest expense (income), net operating--------
Unusual expense (income)3-11533
Other operating expenses, total-210111
Operating income322422257239
Interest income (expense), net non-operating-37-35---36
Gain (loss) on sale of assets--------
Other--------
Income before tax300392182214
Income after tax205209114200
Income tax, total951836814
Net income192195102188
Total adjustments to net income-2-100
Net income before extra. items192195102188
Minority interest-13-14-12-12
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items190194102188
Inc. avail. to common incl. extra. items190194102188
Diluted net income192194102188
Dilution adjustment2------
Diluted weighted average shares142142144145
Diluted EPS excluding extraordinary itemsvalue per share1.351.370.711.30
Dividends per sharevalue per share0.400.400.400.38
Diluted normalized EPSvalue per share1.370.930.721.32